[go: up one dir, main page]

DE60002226D1 - Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte - Google Patents

Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte

Info

Publication number
DE60002226D1
DE60002226D1 DE60002226T DE60002226T DE60002226D1 DE 60002226 D1 DE60002226 D1 DE 60002226D1 DE 60002226 T DE60002226 T DE 60002226T DE 60002226 T DE60002226 T DE 60002226T DE 60002226 D1 DE60002226 D1 DE 60002226D1
Authority
DE
Germany
Prior art keywords
carnitin
disorders
prevention
derivatives
circular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60002226T
Other languages
English (en)
Other versions
DE60002226T2 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of DE60002226D1 publication Critical patent/DE60002226D1/de
Application granted granted Critical
Publication of DE60002226T2 publication Critical patent/DE60002226T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60002226T 1999-10-08 2000-10-02 Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte Expired - Lifetime DE60002226T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999RM000618A IT1306722B1 (it) 1999-10-08 1999-10-08 Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
ITRM990618 1999-10-08
PCT/IT2000/000391 WO2001026666A2 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Publications (2)

Publication Number Publication Date
DE60002226D1 true DE60002226D1 (de) 2003-05-22
DE60002226T2 DE60002226T2 (de) 2004-03-04

Family

ID=11406992

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002226T Expired - Lifetime DE60002226T2 (de) 1999-10-08 2000-10-02 Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte

Country Status (21)

Country Link
US (1) US6641849B1 (de)
EP (1) EP1218022B1 (de)
AR (1) AR025790A1 (de)
AT (1) ATE237341T1 (de)
AU (1) AU780643B2 (de)
CA (1) CA2386770C (de)
CZ (1) CZ20021062A3 (de)
DE (1) DE60002226T2 (de)
DK (1) DK1218022T3 (de)
ES (1) ES2195939T3 (de)
HU (1) HU227042B1 (de)
IL (1) IL148963A0 (de)
IT (1) IT1306722B1 (de)
MX (1) MXPA02003501A (de)
NO (1) NO20021640L (de)
PL (1) PL199996B1 (de)
PT (1) PT1218022E (de)
SK (1) SK4052002A3 (de)
TN (1) TNSN00186A1 (de)
TR (1) TR200200948T2 (de)
WO (1) WO2001026666A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
CN1638650A (zh) * 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
ITRM20010708A1 (it) 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101001670B (zh) 2004-05-18 2012-10-03 澳美制药厂有限公司 用于睡眠障碍的组合物
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
ITRM20040561A1 (it) * 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
AR070816A1 (es) * 2008-03-14 2010-05-05 Otsuka Pharma Co Ltd Farmaco de combinacion para tratar trastornos vasculares
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CZ308282B6 (cs) * 2010-08-05 2020-04-15 Výzkumný ústav živočišné výroby, v. v. i. Krmný doplněk pro zvýšení libida kanců
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
ES2666836T3 (es) * 2014-06-04 2018-05-08 Alfasigma S.P.A. Formulaciones homogéneas que comprenden ácidos grasos poliinsaturados omega-3 (n-3 PUFA) y resveratrol para administración oral

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE9318632U1 (de) * 1993-12-06 1995-04-06 Emsa-Werke Wulf GmbH & Co, 48282 Emsdetten Vorrichtung zum Aufnehmen von Folienrollen
US6221356B1 (en) * 1996-12-13 2001-04-24 Viva America Marketing, Inc. Method of preparation of biologically active Ginkgo biloba product
CA2280093A1 (en) 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1294227B1 (it) 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.

Also Published As

Publication number Publication date
SK4052002A3 (en) 2002-09-10
WO2001026666A2 (en) 2001-04-19
ITRM990618A1 (it) 2001-04-08
IL148963A0 (en) 2002-11-10
CZ20021062A3 (cs) 2002-08-14
TNSN00186A1 (fr) 2005-11-10
US6641849B1 (en) 2003-11-04
AU780643B2 (en) 2005-04-07
NO20021640L (no) 2002-05-29
ITRM990618A0 (it) 1999-10-08
MXPA02003501A (es) 2002-09-02
PL354413A1 (en) 2004-01-12
AR025790A1 (es) 2002-12-11
EP1218022B1 (de) 2003-04-16
DE60002226T2 (de) 2004-03-04
CA2386770A1 (en) 2001-04-19
IT1306722B1 (it) 2001-10-02
TR200200948T2 (tr) 2002-10-21
EP1218022A2 (de) 2002-07-03
AU7945600A (en) 2001-04-23
HUP0203449A3 (en) 2005-04-28
NO20021640D0 (no) 2002-04-05
WO2001026666A3 (en) 2001-09-13
ATE237341T1 (de) 2003-05-15
DK1218022T3 (da) 2003-08-11
PT1218022E (pt) 2003-09-30
HUP0203449A2 (hu) 2003-02-28
HU227042B1 (en) 2010-05-28
PL199996B1 (pl) 2008-11-28
CA2386770C (en) 2009-09-08
ES2195939T3 (es) 2003-12-16

Similar Documents

Publication Publication Date Title
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE60026627D1 (de) Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
DE60023873D1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
EP1117395A4 (de) Verbindungen zur behandlung von östrogenabhängigen erkrankungen und deren herstellungs und verwendungsmethoden
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
DE60025215D1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
ATE224711T1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
PL367613A1 (en) Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
ATE316374T1 (de) Antikonvulsive derivate zur behandlung von essentiellem tremor
DE60122114D1 (de) Zusammensetzung zur verhinderung und/oder behandlung von gefässerkrankungen, bestehend aus propionyl-l-carnitin und coenzym q10
DE69918339D1 (de) Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition